SEARCH RESULTS FOR: "Tag: SGMO"
REFINE YOUR SEARCH:
RECENT
Last Week(1)
Last Month(1)
ARTICLES/BLOGS
2019(5)
2018(4)
2017(5)
2015(1)
CATEGORIES
Analyst Update(3)
Analyst Upgrades(1)
Buzz Stocks(2)
Intraday Option Activity(1)
Quantitative Analysis(2)
Stocks On the Move(7)
Technical Analysis(1)

12/9/2019 9:22 AM
The shares of Sangamo Therapeutics Inc (NASDAQ:SGMO) are eyeing a three-month high of $12.25 today, up 5.1% at last check, after the firm shared promising results for its gene-editing therapy ST-40...
7/8/2019 9:53 AM
Two biotech names are making a run up the Nasdaq charts this morning. First there's Sangamo Therapeutics Inc (NASDAQ:SGMO), up 10% to trade at $12.53, after the gene therapy specialist reported positi...
4/2/2019 12:43 PM
The shares of Sangamo Therapeutics Inc (NASDAQ:SGMO) are on fire, after the California-based biotech reported positive data in a phase 1/2 study for its gene therapy hemophilia treatment that's being...
3/12/2019 12:23 PM
Biotech company Sangamo Therapeutics Inc (NASDAQ:SGMO) just named Jason Fontenot, Ph.D. as its Senior Vice President, Cell Therapy. Fontenot will be in charge of the genomic medicine concern's develo...
2/7/2019 2:58 PM
Stocks are staring at stiff losses following fresh U.S.-China trade news. Among individual names making big moves lower are ePort parent USA Technologies, Inc. (NASDAQ:USAT), biotech Sangamo Therap...
Partner Center